GSK Current Deferred Revenue (Quarterly) Insights

GSK Plc (GSK)

49.11 +0.03 (+0.06%) USD | NYSE | Dec 29, 16:00

49.27 +0.16 (+0.33%) After-Hours: 20:00

View Current Deferred Revenue (Quarterly) for GSK.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Current Deferred Revenue (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Current Deferred Revenue (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Current Deferred Revenue (Quarterly) Benchmarks

Start Trial

AstraZeneca PLC	--
Biodexa Pharmaceuticals Plc	Upgrade
NuCana Plc	--
Bicycle Therapeutics Plc	Upgrade
DBV Technologies SA	--